Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06153667 · ClinicalTrials.gov registry record
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
A clinical trial, sponsored by Merit Medical Systems.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT06153667 is a clinical trial that is actively recruiting participants, run by Merit Medical Systems. The registered enrollment target is 100 participants.
The verdict
NCT06153667 is actively recruiting participants, sponsored by Merit Medical Systems.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.
Interventions
- DEVICE Bearing nsPVA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06153667
The ClinicalTrials.gov registry entry for NCT06153667 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bearing nsPVA is the first listed.
NCT06153667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06153667 about?
NCT06153667 is a clinical study titled "Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)". This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.
What is the current status of trial NCT06153667?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-08-22. Estimated completion is 2026-12.
What interventions are being tested in trial NCT06153667?
The interventions under investigation include: Bearing nsPVA (DEVICE).
Who is sponsoring clinical trial NCT06153667?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.